Literature DB >> 16225787

HIV diversity, molecular epidemiology, and the role of recombination.

Gustavo H Kijak1, Francine E McCutchan.   

Abstract

The magnitude of the HIV pandemic and its extensive genetic variation may earn it a unique place among infectious agents. A high mutation rate and a rampant recombination are driving HIV's evolution. Nine subtypes and a variety of recombinant forms of HIV now exist. The source of recombinant forms is the multiple infection of target cells, which becomes highly significant when individuals become infected with two or more divergent strains. In the current paper, we re-examine the role of dual infection and recombination in the generation of HIV-1 diversity, both in individuals and on a global scale. The current molecular epidemiology of HIV-1 is reviewed, emphasizing the latest reports from regional epidemics.

Entities:  

Year:  2005        PMID: 16225787     DOI: 10.1007/s11908-005-0051-8

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  54 in total

Review 1.  Understanding the genetic diversity of HIV-1.

Authors:  F E McCutchan
Journal:  AIDS       Date:  2000       Impact factor: 4.177

Review 2.  Lost in translation: implications of HIV-1 codon usage for immune escape and drug resistance.

Authors:  Gustavo H Kijak; Jeffrey R Currier; Sodsai Tovanabutra; Josephine H Cox; Nelson L Michael; Scott A Wegner; Deborah L Birx; Francine E McCutchan
Journal:  AIDS Rev       Date:  2004 Jan-Mar       Impact factor: 2.500

3.  Molecular characterization of HIV type 1 isolates from untreated patients of Mumbai (Bombay), India, and detection of rare resistance mutations.

Authors:  Alaka Deshpande; Patricia Recordon-Pinson; Ranjana Deshmukh; Muriel Faure; Valérie Jauvin; Isabelle Garrigue; Marie-Edith Lafon; Hervé J Fleury
Journal:  AIDS Res Hum Retroviruses       Date:  2004-09       Impact factor: 2.205

4.  Emergence of HIV-1 CRF01_AE/B unique recombinant forms in Kuala Lumpur, Malaysia.

Authors:  Kok Keng Tee; Chee Keong Pon; Adeeba Kamarulzaman; Kee Peng Ng
Journal:  AIDS       Date:  2005-01-28       Impact factor: 4.177

5.  Human immunodeficiency virus type 1 clade B superinfection: evidence for differential immune containment of distinct clade B strains.

Authors:  Otto O Yang; Eric S Daar; Beth D Jamieson; Arumugam Balamurugan; Davey M Smith; Jacqueline A Pitt; Christos J Petropoulos; Douglas D Richman; Susan J Little; Andrew J Leigh Brown
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

6.  Frequency of HIV-1 dual subtype infections, including intersubtype superinfections, among injection drug users in Bangkok, Thailand.

Authors:  Dale J Hu; Shambavi Subbarao; Suphak Vanichseni; Philip A Mock; Artur Ramos; Lily Nguyen; Thanyanan Chaowanachan; Frits van Griensven; Kachit Choopanya; Timothy D Mastro; Jordan W Tappero
Journal:  AIDS       Date:  2005-02-18       Impact factor: 4.177

7.  The molecular epidemiology of HIV type 1 among Vietnamese Australian injecting drug users in Melbourne, Australia.

Authors:  Claire E Ryan; Julian H Elliott; Tracey Middleton; Anne M Mijch; Alan C Street; Margaret Hellard; Nick Crofts; Suzanne M Crowe; Robert B Oelrichs
Journal:  AIDS Res Hum Retroviruses       Date:  2004-12       Impact factor: 2.205

8.  Nigerian HIV type 2 subtype A and B from heterotypic HIV type 1 and HIV type 2 or monotypic HIV type 2 infections.

Authors:  Clement Zeh; Danuta Pieniazek; Simon M Agwale; Kenneth E Robbins; Lillian Odama; N Sani-Gwarzo; Michael S Gboun; Uford S Inyang; Thomas M Folks; Charles Wambebe; Marcia L Kalish
Journal:  AIDS Res Hum Retroviruses       Date:  2005-01       Impact factor: 2.205

9.  High genetic diversity of human immunodeficiency virus type 1 in Angola.

Authors:  Inês Bártolo; Marta Epalanga; José Bartolomeu; Marlene Fonseca; Ana Mendes; António Gama; Nuno Taveira
Journal:  AIDS Res Hum Retroviruses       Date:  2005-04       Impact factor: 2.205

10.  Infection with HIV type 1 group M non-B subtypes in individuals living in New York City.

Authors:  Jacqueline M Achkar; Sherri T Burda; Frank A J Konings; Mateusz M Urbanski; Constance A U Williams; Dorothee Seifen; Martha N Kahirimbanyi; Mary Vogler; Mark Parta; Helene C Lupatkin; Susan Zolla-Pazner; Phillipe N Nyambi
Journal:  J Acquir Immune Defic Syndr       Date:  2004-07-01       Impact factor: 3.731

View more
  25 in total

1.  RecDraw: a software package for the representation of HIV-1 recombinant structures.

Authors:  Gustavo H Kijak; Sodsai Tovanabutra; Chris Beyrer; Eric E Sanders-Buell; Miguel A Arroyo; Merlin L Robb; Nelson L Michael; Francine E McCutchan; Jerome H Kim
Journal:  AIDS Res Hum Retroviruses       Date:  2010-10-21       Impact factor: 2.205

2.  Natural killer cell-mediated innate sieve effect on HIV-1: the impact of KIR/HLA polymorphism on HIV-1 subtype-specific acquisition in east Africa.

Authors:  Rebecca N Koehler; Galit Alter; Sodsai Tovanabutra; Elmar Saathoff; Miguel A Arroyo; Anne M Walsh; Eric E Sanders-Buell; Leonard Maboko; Michael Hoelscher; Merlin L Robb; Nelson L Michael; Francine E McCutchan; Jerome H Kim; Gustavo H Kijak
Journal:  J Infect Dis       Date:  2013-08-06       Impact factor: 5.226

3.  Dynamics of viral evolution and neutralizing antibody response after HIV-1 superinfection.

Authors:  Antoine Chaillon; Gabriel A Wagner; N Lance Hepler; Susan J Little; Sergei L Kosakovsky Pond; Gemma Caballero; Mary E Pacold; Pham Phung; Terri Wrin; Douglas D Richman; Joel O Wertheim; Davey M Smith
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

4.  Near full-length genomic characterization of a novel HIV type 1 CRF07_ BC/01_AE recombinant in men who have sex with men from Sichuan, China.

Authors:  Huamian Wei; Ling Su; Yi Feng; Xiang He; Jenny His; Shu Liang; Yiming Shao
Journal:  AIDS Res Hum Retroviruses       Date:  2013-05-21       Impact factor: 2.205

5.  Molecular evolution of the HIV-1 Thai epidemic between the time of RV144 immunogen selection to the execution of the vaccine efficacy trial.

Authors:  Gustavo H Kijak; Sodsai Tovanabutra; Supachai Rerks-Ngarm; Sorachai Nitayaphan; Chirapa Eamsila; Prayura Kunasol; Chirasak Khamboonruang; Prasert Thongcharoen; Chawetsan Namwat; Nakorn Premsri; Michael Benenson; Patricia Morgan; Meera Bose; Eric Sanders-Buell; Robert Paris; Merlin L Robb; Deborah L Birx; Mark S De Souza; Francine E McCutchan; Nelson L Michael; Jerome H Kim
Journal:  J Virol       Date:  2013-04-10       Impact factor: 5.103

6.  Vaccine induced antibodies to the first variable loop of human immunodeficiency virus type 1 gp120, mediate antibody-dependent virus inhibition in macaques.

Authors:  Izabela Bialuk; Stephen Whitney; Vibeke Andresen; Ruth H Florese; Janos Nacsa; Valentina Cecchinato; Valerio W Valeri; Jean-Michel Heraud; Shari Gordon; Robyn Washington Parks; David C Montefiori; David Venzon; Thorsten Demberg; Marjorie Robert- Guroff; Gary Landucci; Donald N Forthal; Genoveffa Franchini
Journal:  Vaccine       Date:  2011-10-27       Impact factor: 3.641

Review 7.  Pathogen-pathogen interaction: a syndemic model of complex biosocial processes in disease.

Authors:  Merrill Singer
Journal:  Virulence       Date:  2010 Jan-Feb       Impact factor: 5.882

Review 8.  Deep sequencing: becoming a critical tool in clinical virology.

Authors:  Miguel E Quiñones-Mateu; Santiago Avila; Gustavo Reyes-Teran; Miguel A Martinez
Journal:  J Clin Virol       Date:  2014-06-24       Impact factor: 3.168

9.  HIV-1 variable loop 2 and its importance in HIV-1 infection and vaccine development.

Authors:  Mangala Rao; Kristina K Peachman; Jiae Kim; Guofen Gao; Carl R Alving; Nelson L Michael; Venigalla B Rao
Journal:  Curr HIV Res       Date:  2013-07       Impact factor: 1.581

10.  Longitudinal analysis of intra-host simian immunodeficiency virus recombination in varied tissues of the rhesus macaque model for neuroAIDS.

Authors:  Susanna L Lamers; David J Nolan; Samantha L Strickland; Mattia Prosperi; Gary B Fogel; Maureen M Goodenow; Marco Salemi
Journal:  J Gen Virol       Date:  2013-08-20       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.